Photo from Elisa Agostinetto/X
May 18, 2024, 04:13
Elisa Agostinetto: Is this a new predictive biomarker for PFS with camizestrant
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on X/Twitter:
”At ESMO Breast24 exploratory analysis of SERENA-2: compared to fulvestrant, camizestrant decreases ctDNA ESR1 mutations in ER+/HER2- mBC.
Is this a new predictive biomarker for PFS with camizestrant?”
Source: Elisa Agostinetto/X
Aug 11, 2024, 14:12